Progressive publishes new research

RNS Number : 3682L

SDI Group PLC

12 January 2021

 

Building on its proven growth track record SDI Group is an AIM-quoted group specialising in the acquisition and development of a portfolio of companies that design and manufacture products for use in digital imaging and sensing and control applications in science, technology and medical markets. Corporate expansion is pursued, through organic growth and the acquisition of high-quality businesses with established reputations in global markets. The coronavirus pandemic has weighed on most group businesses, but one-off COVID-19 related contracts have significantly boosted sales of two product lines and growth has been enhanced by the recently announced acquisition of Monmouth Scientific, leading us to forecast 33% revenue growth and improved profitability in the current financial year, with cash generation also expected to remain strong.

Click here for full analysis

Subscribe   to Progressive's research, which is freely available to every type of investor, and be kept informed about our regular programme of investor engagement. 

About Progressive:

Progressive helps you make informed investment decisions. FCA authorised and regulated, and with a 15-strong team of highly experienced analysts, we provide freely available institutional grade equity research and access to company management teams across every sector of the market.

www.progressive-research.com

Broad coverage		Analyst calibre
across 12 sectors
Business Services	Oil & Gas	15 analysts	with average	20 years
Financials	Property		experience of
Healthcare	Retail
Industrials	Technology	30+		techMARK
Investment Trusts	Telecoms		industry based	Extel
Mining	Utilities		awards	StarMine

For further information please contact:

Emily Ritchie

[phone]

[e-mail]

 

END

 

 

NRAMZGMMNZLGMZG